286 related articles for article (PubMed ID: 34533304)
1. The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia.
von Bartheld CS; Hagen MM; Butowt R
ACS Chem Neurosci; 2021 Oct; 12(19):3535-3549. PubMed ID: 34533304
[TBL] [Abstract][Full Text] [Related]
2. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
[TBL] [Abstract][Full Text] [Related]
3. Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.
Huang SY; Kung YA; Huang PN; Chang SY; Gong YN; Han YJ; Chiang HJ; Liu KT; Lee KM; Chang CY; Chang CC; Huang CG; Shih SR
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789940
[TBL] [Abstract][Full Text] [Related]
4. Estimating the transmission advantage of the D614G mutant strain of SARS-CoV-2, December 2019 to June 2020.
Leung K; Pei Y; Leung GM; Lam TT; Wu JT
Euro Surveill; 2021 Dec; 26(49):. PubMed ID: 34886945
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences.
von Bartheld CS; Hagen MM; Butowt R
ACS Chem Neurosci; 2020 Oct; 11(19):2944-2961. PubMed ID: 32870641
[TBL] [Abstract][Full Text] [Related]
6. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
Elife; 2021 Feb; 10():. PubMed ID: 33570490
[TBL] [Abstract][Full Text] [Related]
7. dsmCRISPR: Dual synthetic mismatches CRISPR/Cas12a-based detection of SARS-CoV-2 D614G mutation.
Huang X; Zhang F; Zhu K; Lin W; Ma W
Virus Res; 2021 Oct; 304():198530. PubMed ID: 34363850
[TBL] [Abstract][Full Text] [Related]
8. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility.
Shi PY; Plante J; Liu Y; Liu J; Xia H; Johnson B; Lokugamage K; Zhang X; Muruato A; Zou J; Fontes-Garfias C; Mirchandani D; Scharton D; Kalveram B; Bilello J; Ku Z; An Z; Freiberg A; Menachery V; Xie X; Plante K; Weaver S
Res Sq; 2020 Sep; ():. PubMed ID: 32935091
[TBL] [Abstract][Full Text] [Related]
9. Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility.
Plante JA; Liu Y; Liu J; Xia H; Johnson BA; Lokugamage KG; Zhang X; Muruato AE; Zou J; Fontes-Garfias CR; Mirchandani D; Scharton D; Bilello JP; Ku Z; An Z; Kalveram B; Freiberg AN; Menachery VD; Xie X; Plante KS; Weaver SC; Shi PY
bioRxiv; 2020 Sep; ():. PubMed ID: 32908978
[TBL] [Abstract][Full Text] [Related]
10. New study on prevalence of anosmia in COVID-19 implicates the D614G virus mutation as a major contributing factor to chemosensory dysfunction.
von Bartheld CS; Mathew D; Butowt R
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3593-3594. PubMed ID: 33788036
[No Abstract] [Full Text] [Related]
11. Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor.
Butowt R; Bilinska K; Von Bartheld CS
ACS Chem Neurosci; 2020 Oct; 11(20):3180-3184. PubMed ID: 32997488
[TBL] [Abstract][Full Text] [Related]
12. Detection of SARS-CoV-2 spike protein D614G mutation using μTGGE.
Juma KM; Morimoto K; Sharma V; Sharma K; Biyani R; Biyani M; Takita T; Yasukawa K
Mol Biol Rep; 2024 Feb; 51(1):289. PubMed ID: 38329653
[TBL] [Abstract][Full Text] [Related]
13. Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019.
Butowt R; Bilińska K; von Bartheld C
J Infect Dis; 2022 Oct; 226(8):1304-1308. PubMed ID: 35467743
[TBL] [Abstract][Full Text] [Related]
14. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
Benton DJ; Wrobel AG; Roustan C; Borg A; Xu P; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33579792
[TBL] [Abstract][Full Text] [Related]
15. Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.
Lee CY; Amrun SN; Chee RS; Goh YS; Mak TM; Octavia S; Yeo NK; Chang ZW; Tay MZ; Torres-Ruesta A; Carissimo G; Poh CM; Fong SW; Bei W; Lee S; Young BE; Tan SY; Leo YS; Lye DC; Lin RT; Maurer-Stroh S; Lee B; Wang CI; Renia L; Ng LF
Clin Transl Immunology; 2021; 10(2):e1241. PubMed ID: 33628442
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary dynamics of SARS-CoV-2 circulating in Yogyakarta and Central Java, Indonesia: sequence analysis covering furin cleavage site (FCS) region of the spike protein.
Wijayanti N; Gazali FM; Supriyati E; Hakim MS; Arguni E; Daniwijaya MEW; Nuryastuti T; Nuhamunada M; Nabilla R; Haryana SM; Wibawa T
Int Microbiol; 2022 Aug; 25(3):531-540. PubMed ID: 35165816
[TBL] [Abstract][Full Text] [Related]
17. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
18. Making sense of spike D614G in SARS-CoV-2 transmission.
Shi AC; Xie X
Sci China Life Sci; 2021 Jul; 64(7):1062-1067. PubMed ID: 33587268
[TBL] [Abstract][Full Text] [Related]
19. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.
Ozono S; Zhang Y; Ode H; Sano K; Tan TS; Imai K; Miyoshi K; Kishigami S; Ueno T; Iwatani Y; Suzuki T; Tokunaga K
Nat Commun; 2021 Feb; 12(1):848. PubMed ID: 33558493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
